Gene Therapy: Preventing Overmedicalization with Clear Guidelines, Education, and Shared Decision-Making

In the context of gene therapy, the prevention of overmedicalization can be approached through several key points. Firstly, it is crucial to establish clear guidelines and criteria for the use of gene therapy, ensuring that it is reserved for cases where it is truly necessary and beneficial. This can help prevent unnecessary use and the potential risks associated with it. Secondly, promoting education and awareness among both healthcare professionals and the general public is essential. By providing accurate and evidence-based information about the benefits, limitations, and potential risks of gene therapy, individuals can make informed decisions and avoid unnecessary treatments. Lastly, fostering a culture of shared decision-making between patients and healthcare providers is paramount. Encouraging open discussions about the potential benefits and risks of gene therapy, while considering individual preferences and values, can help prevent overmedicalization and ensure that treatment choices align with patients' needs and goals.